ACCELERA PART OF NMS GROUP Trademark

Trademark Overview


On Friday, July 9, 2021, a trademark application was filed for ACCELERA PART OF NMS GROUP with the United States Patent and Trademark Office. The USPTO has given the ACCELERA PART OF NMS GROUP trademark a serial number of 79325436. The federal status of this trademark filing is REGISTERED as of Tuesday, January 10, 2023. This trademark is owned by ACCELERA S.R.L.. The ACCELERA PART OF NMS GROUP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, technological, analysis and research services, namely, research and development in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; Scientific research in the nature of conducting clinical trials in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, product testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services
accelera part of nms group

General Information


Serial Number79325436
Word MarkACCELERA PART OF NMS GROUP
Filing DateFriday, July 9, 2021
Status700 - REGISTERED
Status DateTuesday, January 10, 2023
Registration Number6945266
Registration DateTuesday, January 10, 2023
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Translation of Words in MarkThe English translation of "ACCELERA" in the mark is "ACCELERATE".
NOT AVAILABLE"PART OF NMS GROUP"
Goods and ServicesScientific, technological, analysis and research services, namely, research and development in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; Scientific research in the nature of conducting clinical trials in the field of medicine, specifically, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, product testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameACCELERA S.R.L.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressIT

Party NameACCELERA S.R.L.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIT

Party NameACCELERA S.R.L.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIT

Trademark Events


Event DateEvent Description
Tuesday, March 29, 2022ASSIGNED TO EXAMINER
Thursday, November 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 19, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 8, 2022NON-FINAL ACTION WRITTEN
Saturday, April 9, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 19, 2022REFUSAL PROCESSED BY MPU
Thursday, May 19, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 6, 2022REFUSAL PROCESSED BY IB
Monday, September 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 12, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, September 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 10, 2023REGISTERED-PRINCIPAL REGISTER
Monday, April 10, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 17, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 1, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 25, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 24, 2023FINAL DISPOSITION PROCESSED